Simultaneous Determination of Five Irdoid Glycosides and Three Flavonoid Glycosides in Hedyotis Diffusa Wild by UPLC-UV with Ultrasound-Assisted Extraction

Author:

Huang Xuliang1,Wu Youjia1,Zhang Xiaoying2,Chen Bing2,Luo Hongbin3,Lin Xinhua1,Shi Peiying4,Yao Hong1

Affiliation:

1. Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China

2. Chemical Experiment Center, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China

3. Chemical Experiment Center, School of Pharmacy, Fujian Medical University, Fuzhou 350122, , China

4. Department of Traditional Chinese Medicine Resource and Bee Products, Bee Science College, Fujian Agriculture and Forestry University, Fuzhou, 350002, China

Abstract

Background: Hedyotis diffusa is one of the most extensively used Chinese herbs for the treatment of varieties of cancers in the folk of China. The ingredients of the preparation are still not very clear and the quality control method of the herb medicine requires further improvement. Introduction: In this paper, the quantitative methods for the quality control of H. diffusa were originally developed by using UPLC-UV. Methods: Using the five irdoid glycosides and three flavonoid glycosides previously obtained from H. diffusa as index components, referring to 10-Acetyl Scandoside Methyl Ester (ASME), Scandoside (SD), Deacetyl Aspemloside (DA), Asperulosidic Acid (AA), Asperuloside (AD), Qurecetin-3-OSophoroside (QS), Quercetin-3-O-[2-(6-O-E-Sinapoyl-β-D-Glucopyranosyl]-β-D-Glucopyranosyl (QESGG), and Quercetin-3-O-[2-O-(6-O-E-Feruloyl)-β-D-Glucopyranosyl]-β-Glucopyanoside (QEFGG), the extraction conditions, including solvents, durations, and cycles were optimized firstly. Subsequently, a new UPLC-UV method was originally established to simultaneously determine the eight ingredients in the Chinese herbal medicine. Results: The validated method exhibited good linearity (R2 > 0.999), repeatability (RSD < 3.01%), intra- and inter-day precision (RSD <6.19%) and recoveries (96.31% to 104.22%) for the simultaneous determination of the eight ingredients studied and had been used for the quality analysis of 6 batches of H. diffusa sameples. Conclusion: The established UPLC-UV method could serve as a rapid and effective tool for quality evaluation of the herbal medicine, H. diffusa.

Funder

Innovation of science and Technology, Fujian province

Fujian Provincial Natural Science Foundation

National Nature Science Foundation of China

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Molecular Medicine,Biochemistry,Biophysics

Reference19 articles.

1. Sun G.; Wei L.; Feng J.; Lin J.; Peng J.; Inhibitory effects of Hedyotis diffusa Willd on colorectal cancer stem cells. Oncol Lett 2016,11(6),3875-3881

2. Li Y.; Zhang J.; Min D.; Hongyan Z.; Lin N.; Li Q.S.; Anticancer effects of 1,3-Dihydroxy-2-Methylanthraquinone and the ethyl acetate fraction of Hedyotis diffusa Willd against HepG2 carcinoma cells mediated via apoptosis. PLoS One 2016,11(4)

3. Zhang P.; Zhang B.; Gu J.; Hao L.; Hu F.; Han C.; The study of the effect of Hedyotis diffusa on the proliferation and the apoptosis of the cervical tumor in nude mouse model. Cell Biochem Biophys 2015,72(3),783-789

4. Yoshida Y.; Wang M.Q.; LIU, J.N.; Shan, B.E.; Yamashita, U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 1997,19(7),359-370

5. Kuo Y.J.; Lin J.P.; Hsiao Y.T.; Chou G.L.; Tsai Y.H.; Chiang S.Y.; Lin J.G.; Chung J.G.; Ethanol extract of Hedyotis diffusa Willd affects immune responses in normal Balb/c mice in vivo. In Vivo 2015,29(4),453

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3